An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma

PURPOSE: Bendamustine plus rituximab has been reported to be effective in treating lymphoid malignancies. This analysis investigated the potential for drug–drug interactions between the drugs in patients with indolent non-Hodgkin lymphoma or mantle cell lymphoma. METHODS: Data were derived from a be...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Mona, Burke, John M., Hellriegel, Edward, Robertson, Philmore, Phillips, Luann, Ludwig, Elizabeth, Munteanu, Mihaela C., Bond, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032641/
https://www.ncbi.nlm.nih.gov/pubmed/24677018
http://dx.doi.org/10.1007/s00280-014-2445-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032641/
https://www.ncbi.nlm.nih.gov/pubmed/24677018
http://dx.doi.org/10.1007/s00280-014-2445-5

Ejemplares similares